Altamira Therapeutics Ltd. Deferred Tax Relating To Items Charged Or Credited Directly To Equity
Altamira Therapeutics Ltd. (CYTOF) reported Deferred Tax Relating To Items Charged Or Credited Directly To Equity of CHF 0 for the 12-month period ending 2018-12-31, per its 20-F filed 2019-03-14.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity · last filed 2019-03-14
| Period end | Deferred Tax Relating To Items Charged Or Credited Directly To Equity 12 month |
|---|---|
| 2018-12-31 | 0.00 CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | 0.00 CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 0.00 CHF 20-F · filed 2018-03-22 |